At the end of the day, the most important question is a simple one: Do you actually know if you’re being reimbursed correctly? The post What Healthcare Organizations Miss When It Comes to Reimbursement Accuracy appeared first on MedCity News.
In healthcare, enterprises are moving slower than the hype cycle would lead you to believe. That said, they’re not moving slowly – they are saying yes to AI, as long as it can solve for specific workflow needs. The post Founders Should Stop Worrying If They’re “AI Enough” appeared first on MedCity News.
Gilead Sciences and Arcellx have been collaborating on the multiple myeloma cell therapy anito-cel since 2022. This therapy was designed to provide better safety, which would be an advantage over Carvykti, the blockbuster multiple myeloma product marketed by Johnson & Johnson and Legend Biotech. The post Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma…
This factsheet discusses HPV and related cancers, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines.
Health care in the United States is confusing for patients and consumers. Price transparency is a step in the right direction — transformative change can happen by combining cost, quality, appropriateness and efficiency measures. The post Healthcare Price Transparency is Not Enough appeared first on MedCity News.
[Sponsored] Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. The post The Healthcare Payments Industry Has a Perception Problem appeared first on MedCity News.
It’s time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management. The post Acuity-driven Care — Leveraging Multi-level Monitoring for Complex Needs appeared first on MedCity News.
The future of healthcare will be one where technology doesn’t just serve the industry but genuinely improves the lives of individuals, transforming how we interact with medical data, healthcare providers, and our personal well-being. The post Four AI Disruptions in 2025 That Will Reshape Pharma and Healthcare appeared first on MedCity News.
Solutions like AI-powered patient intake offer a tangible ROI by streamlining administrative tasks, reducing errors, and improving care quality. The post Let’s Rethink AI — Patient Intake Is the Perfect Place to Start appeared first on MedCity News.
The FDA has approved UCB’s Kygevvi for treating children and adults with thymidine kinase 2 deficiency, an inherited mitochondrial disorder. It’s the drugmaker’s first ultra-rare disease product. The post UCB Drug Becomes First FDA-Approved Treatment for Ultra-Rare and Fatal Mitochondrial Disease appeared first on MedCity News.